Menu Search
Equities

Reckitt Benckiser Group PLC

  • Add to watchlist
  • Add to portfolio
  • Add an alert
3RBB:STU

Reckitt Benckiser Group PLC

Actions
  • Price (EUR)11.50
  • Today's Change-0.20 / -1.71%
  • Shares traded0.00
  • 1 Year change+12.75%
  • Beta0.4045
Data delayed at least 15 minutes, as of Jul 11 2025.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Reckitt Benckiser Group PLC (Reckitt) is a United Kingdom-based global consumer goods company. The Company's operating segments comprise the Hygiene, Health, and Nutrition business. The Hygiene portfolio works to eliminate dirt, germs, pests, and odors with products such as Lysol, Finish, Air Wick, Harpic and Mortein. The Company’s Health portfolio offers various solutions that provide pain relief, protection, hygiene, and personal care to households across the world, through brands like Dettol, Durex, Gaviscon, Nurofen, Mucinex, Strepsils and Veet. The Nutrition business includes its infant and child nutrition, its adult nutrition and its range of vitamins, minerals, and supplements (VMS). Brands under Nutrition business include Enfa, Enfamil, Nutramigen, Airborne, Move Free and Neuriva. The Company’s brands also include Dettol, Lysol, Harpic, Finish, Durex, Mucinex, Enfamil and Move Free and more.

  • Revenue in USD (TTM)19.13bn
  • Net income in USD1.93bn
  • Incorporated2007
  • Employees37.90k
  • Location
    Reckitt Benckiser Group PLC103-105 Bath RoadSLOUGH SL1 3UHUnited KingdomGBR
  • Phone+44 175 321 7800
  • Fax+44 175 321 7899
  • Websitehttps://www.reckitt.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.